OR WAIT 15 SECS
© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
January 04, 2021
Vibegron (Gemtesa; Sumitovant Biopharma) 75 mg tablets are indicated to treat patients with an overactive bladder.
December 28, 2020
The Drug Topics® team rounded up some of our top-read articles from the last year.
December 14, 2020
Pharmacists can counsel patients on how to best manage heartburn and GERD symptoms.
November 16, 2020
Recent research offers insight into the global prevalence of gastrointestinal disorders.
Regular use of proton pump inhibitors could increase the risk of developing diabetes, but the findings are based off an observational study.
November 12, 2020
Results of 2 recent studies suggested a higher risk of developing osteoporosis in patients with inflammatory bowel disease.
The sodium sulfate, magnesium sulfate, and potassium chloride tablet gives patients an alternative to liquid-based colonoscopy preparations.
October 22, 2020
Eli Lilly reported new efficacy and safety data for mirikizumab in moderate-to-severe Crohn disease.
October 15, 2020
An altered composition of the gut microbiota might play a role in major depressive disorder and affect treatment response.
October 08, 2020
Results of the phase 2b study showed that, in its highest-dosing arm, 21% of patients with left-sided ulcerative colitis were in clinical remission.